34 , 35 Our data showed a trend (not statistically significant) toward the highest sIL2R levels in patients with both DISR and melanoma progression (approximately 3.5 times the upper limit of normal [ULN]).
← all excerpts
Soluble IL-2 receptor levels support diagnosis of sarcoidosis-like reaction in melanoma patients on immunotherapy - a diagnostic algorithm based on a single center retrospective study.
1
—
—